Zdrowie i gospodarka · 17/01/2017

FDA Releases Draft Guidance on Referencing Approved Drug Products in ANDA Submissions

The US Food and Drug Administration (FDA) has made available a draft guidance document for industry, outlining the process for referencing approved drug products in abbreviated new drug application (ANDA) submissions, which allow generic drug manufacturers to seek FDA approval to market their versions of previously approved medications.